In this interview, Anna Johnson, Editor, Business Fights Poverty set out to explore how ViiV Healthcare has been able to enhance the accessibility and affordability of life-saving HIV drug, dolutegravir (DTG), through a strategic approach to partnering with Helen McDowell, Head of Government Affairs and Global Public Health, ViiV Healthcare